Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX2PNQ
|
||||
Drug Name |
4-cyclopropylmethyl-23-oxo-8-oxa-1,15,17,21-tetraazapentacyclo[19.2.2.13,7.19,13.015,19]heptacosa-3(27),4,6,9(26),10,12,16,18-octaen-10-yl cyanide
|
||||
Synonyms |
CHEMBL424338
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C27H27N5O2
|
||||
Canonical SMILES |
O=C1CN2CCN1Cc3cc(Oc4cc(Cn5cncc5C2)ccc4C#N)ccc3CC6CC6
|
||||
InChI |
InChI=1S/C27H27N5O2/c28-12-22-4-3-20-10-26(22)34-25-6-5-21(9-19-1-2-19)23(11-25)15-31-8-7-30(17-27(31)33)16-24-13-29-18-32(24)14-20/h3-6,10-11,13,18-19H,1-2,7-9,14-17H2
|
||||
InChIKey |
MFPPMKRAKTUYMX-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.